IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

264.53 0.74 +0.28%
Market cap
$43.7B
P/E
31.8×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
32.29 23.77 20.95 28.43

+8 more quarters

P/S ratio
2.56 1.89 1.73 2.38
P/FCF ratio
21.30 14.21 13.11 18.23
P/Operating CF
53.67 57.52 46.47 52.72
P/B ratio
6.52 5.09 4.52 5.84
EV/Sales
3.35 2.71 2.55 3.21
EV/EBITDA
16.74 13.51 12.52 15.63
EV/FCF
27.86 20.37 19.37 24.61
Current Ratio
0.83 0.71 0.75 0.75
Net Debt/EBITDA
15.19 17.31 16.99 14.30
Debt/Equity
2.37 2.54 2.49 2.37
Earnings Yield
3.10% 4.21% 4.77% 3.52%
Free Cash Flow Yield
4.70% 7.04% 7.63% 5.49%
Free Cash Flow per Share
4.05 2.17 2.92 3.26
Book value per Share
41.23 37.94 37.70 38.57
Free Cash Flow
667.00 360.00 491.00 561.00
EV/EBIT
26.10 20.91 19.30 23.98
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026